Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director and Enters Cooperation Agreement With Shareholder Mkt Capital
EDMONTON, AB — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) announced that its Board of Directors (“the Board”) has appointed Dr. Robert T. Foster to the Board. MKT… Read More




